http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4602007-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-38
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-38
filingDate 1984-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1986-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9045b10a368fafb7e351c84b75e2dcbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d992d3c2b40db41d4872552b9c20d6b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5863a9faf4889a6f211359e8204b080e
publicationDate 1986-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4602007-A
titleOfInvention Salicylate culture media for inactivation of bacterial growth inhibitors
abstract This invention encompasses methods and reagents for inactivation of bacterial growth inhibitors present in blood, serum or plasma. It has been found that salicylates and closely related compounds will neutralize bacterial growth inhibitors present in the blood of many patients. The addition of salicylate to conventional growth medium also provides a reagent for monitoring the antibiotic levels in blood by enabling measurement of the effect of the antibiotic against a standard test organism without interference from the bacterial growth inhibitor present in sera.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009297594-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8114435-B2
priorityDate 1980-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4340679-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3671399-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4483926-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57134040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663629
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394128
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16760658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226773371
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135988791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405879
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37768
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226481152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129251513
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3469
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36294
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136214625
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129649604
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23664627
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5147
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395817

Total number of triples: 51.